3D Printing: Emerging Technologies and Functionality of Polymeric Excipients in Drug Product Development: 44 - Rilegato

 
9783031460142: 3D Printing: Emerging Technologies and Functionality of Polymeric Excipients in Drug Product Development: 44
Rilegato
ISBN 10: 3031460146 ISBN 13: 9783031460142
Casa editrice: Springer Nature, 2023

Sinossi

This inclusive text describes 3D Printing for pharmaceutical applications, including emerging 3D technologies. The book focuses on the functionality of the materials/biomaterials used for the preparation of dosage forms and devices, fundamentals for preparing these systems and novel applications using these additive manufacturing techniques.  Also, the text includes clinical relevance and regulatory considerations for the future of personalized medicine.

Authored by experts with a broad range of experience, extensive insight into the science of 3D printing technology used to produce these systems is provided.  Highlighting viewpoints from the academic, polymer excipient, equipment, product development and regulatory communities, this comprehensive text compiles input from industry thought leaders to illustrate strategies and technologies for applying techniques of additive manufacturing for drug product and device development while also providing insight into the path forward for the technology in years to come.  

Le informazioni nella sezione "Riassunto" possono far riferimento a edizioni diverse di questo titolo.

Informazioni sull?autore

Dr. Michael A. Repka is Distinguished Professor of the Department of Pharmaceutics at The University of Mississippi. He is also Founder and Director of the Pii Center for Pharmaceutical Technology. His research interests include the solubilization and delivery of poorly soluble bioactives via Hot Melt Extrusion (HME) technology, while coupling HME techniques with 3D printing to produce patient centric delivery systems . Dr. Repka has established himself as an expert in this major pharmaceutical processing field through his numerous peer-reviewed publications, presentations and scientific talks.

Dr. Nigel Langley is currently the Global Technical Director, Life Sciences at Gaylord Chemical LLC. He has a strong interest in excipient innovation, solubilization, hot melt extrusion and 3D printing.  Dr. Langley has also worked at BASF and Croda International PLC and is the current Chair of IPEC-Americas. 

Dalla quarta di copertina

This book is an educational text and guide for the use and properties of key polymeric excipients in the area of 3D printing in drug development. It is written by both industry experts and academic researchers.  The particular focus is on hot melt extrusion and the extruded filaments suitable for optimizing the 3D printing in drug development. 3D Printing Polymeric Excipients, Technology, and Drug Formulation Development covers regulatory aspects as well as the manufacturing aspects.

Le informazioni nella sezione "Su questo libro" possono far riferimento a edizioni diverse di questo titolo.

Editore
Springer Nature
Data di pubblicazione
2023
Lingua
Inglese
ISBN 10 
3031460146
ISBN 13 
9783031460142
Rilegatura
Copertina rigida
Numero edizione
1
Numero di pagine
288
Redattore
Repka Michael A., Langley Nigel
Contatto del produttore
non disponibile
Persona responsabile
Palgrave Macmillan
ProductSafety@springernature.com

Crinan Street 4
London
N1 9XW
Regno Unito

Altre edizioni note dello stesso titolo

9783031460173: 3D Printing: Emerging Technologies and Functionality of Polymeric Excipients in Drug Product Development: 44

Edizione in evidenza

ISBN 10:  3031460170 ISBN 13:  9783031460173
Casa editrice: Springer, 2024
Brossura